Stifel Maintains Buy on ClearPoint Neuro, Raises Price Target to $25

Benzinga · 04/01 12:49
Stifel analyst Mathew Blackman maintains ClearPoint Neuro (NASDAQ:CLPT) with a Buy and raises the price target from $19 to $25.